Viral nucleotide changes in asymptomatic hepatitis B carriers undergoing interferon treatment

Aliment Pharmacol Ther. 1996 Apr;10(2):199-202. doi: 10.1046/j.1365-2036.1996.718898000.x.

Abstract

Background: Interferon might induce mutation in regions of hepatitis B virus DNA that encode for immunologic target of cytotoxic T lymphocytes.

Aim: To investigate the short-term effect of steroid priming and interferon therapy on hepatitis B virus, we followed the nucleotide changes in the precore and core region of hepatitis B virus DNA in seven healthy asymptomatic carriers who underwent steroid priming followed by recombinant alpha interferon for 3 months.

Methods: Hepatitis B virus DNA from serial sera of the patients were polymerase chain reaction-amplified, and the precore and core region directly sequenced and analysed.

Results: Analysis revealed no serial changes in the hepatitis B virus nucleotide sequence in any of the patients.

Conclusions: Steroid priming and short-term treatment with interferon in healthy asymptomatic patients does not select for hepatitis B virus with mutations in the precore and core region.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-Inflammatory Agents / therapeutic use
  • Base Sequence
  • Carrier State / blood*
  • DNA, Viral / drug effects*
  • Female
  • Hepatitis B / therapy*
  • Hepatitis B virus / drug effects*
  • Hepatitis B virus / genetics
  • Humans
  • Interferons / therapeutic use*
  • Male
  • Molecular Sequence Data
  • Prednisolone / therapeutic use

Substances

  • Anti-Inflammatory Agents
  • DNA, Viral
  • Interferons
  • Prednisolone